SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 76 filers reported holding SERES THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 1.45 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $158,000 | +13.7% | 14,000 | 0.0% | 0.12% | +5.4% |
| Q4 2016 | $139,000 | -19.2% | 14,000 | 0.0% | 0.11% | +15.6% |
| Q3 2016 | $172,000 | -70.9% | 14,000 | -31.2% | 0.10% | -83.2% |
| Q2 2016 | $591,000 | -8.4% | 20,339 | -16.3% | 0.57% | +14.4% |
| Q1 2016 | $645,000 | -44.3% | 24,300 | -26.4% | 0.50% | -34.8% |
| Q4 2015 | $1,158,000 | – | 33,000 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |